The FTC and DOJ recently shared concerns about the anticompetitive potential of AI. More specifically, the use of AI to aggregate data in a way that could result in collusion. This moderated discussion with enforcement agencies will flag areas of concern as it pertains to the use of AI/ML in managed care and the potential for anticompetitive outcomes.
Featured People
- Antitrust & Competition
- Intellectual Property
- International & Cross-Border
- Business Commercial
- Employment Law
- Entertainment & Sports
- Health Care
- Insurance
- Professional Liability
- Environmental Law
- Real Property
- Special Master Discovery Referee
- Cybersecurity & Privacy
- Higher Education & Title IX
- Life Sciences